MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cells
MAPK4 沉默与 PARP1 抑制剂联合用于三阴性乳腺癌细胞的治疗
期刊:Molecular Medicine Reports
影响因子:3.4
doi:10.3892/mmr.2021.12187
Xiaoqi Zeng, Shanshan Jiang, Simin Ruan, Zhaoze Guo, Jingyun Guo, Minfeng Liu, Changsheng Ye, Jianyu Dong
